Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Orthopedics Market Research

Small Bone and Joint Orthopedics Market Report Suite - Europe - 2018-2024 - MedSuite (Includes 6 Reports)

Best Price Guarantee Length Publisher Published Date SKU
from $11,995 785 Pages iData Research, Inc. June, 2018 IDR15896360
Best Price Guarantee
Price from $11,995
Length 785 Pages
Publisher iData Research, Inc.
Published Date June, 2018
SKU IDR15896360

Small Bone and Joint Orthopedics Market Report Suite - Europe - 2018-2024 - MedSuite (Includes 6 Reports)

The market includes shoulder reconstruction prostheses, elbow repair devices, hand and wrist devices and foot and ankle devices. The growth across all market segments discussed in this report is dampened by price deterioration across Europe, which is particularly visible in the segments that are characterized by higher levels of competition, such as shoulder reconstruction and distal radius plates. Most European countries closely manage their government budget, and governments have applied tender systems in order to reduce spending. Additionally, the markets in some European countries have experienced negative pricing pressure from other countries with historically lower prices.


EXECUTIVE SUMMARY
EUROPEAN SMALL BONE AND JOINT ORTHOPEDIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Elbow
2.1.2 Foot and Ankle
2.1.3 Hand and Wrist
2.1.4 Shoulder
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 Arthritis
2.2.2 Osteoarthritis
2.2.3 Traumatic Injuries
2.2.4 Avascular Necrosis
2.2.5 Congenital Bone Disorder
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics
2.3.2 Osteoporosis Incidence
2.3.3 Arthritis Incidence
PRODUCT ASSESSMENT
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Elbow Reconstruction Device Market
3.2.2 Foot and Ankle Device Market
3.2.3 Hand and Wrist Device Market
3.2.4 Shoulder Reconstruction Device Market
3.2.5 Latest Developments in Joint Reconstruction
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Acumed
3.3.1.1 Plates and Screws
3.3.2 Arthrosurface
3.3.2.1 Various Small Joint Implants and Related Tools
3.3.3 DePuy Synthes
3.3.3.1 Elbow
3.3.3.2 Hand and Wrist
3.3.3.3 Plates and Screws
3.3.3.4 Various Small Joint Implants and Related Tools
3.3.4 Exatech
3.3.4.1 Various Small joint Implants and Related Tools
3.3.5 Integra LifeSciences
3.3.5.1 Foot and Ankle
3.3.5.2 Plates and Screws
3.3.5.3 Various Small joint Implants and Related Tools
3.3.6 Lima Corporate
3.3.6.1 Shoulder
3.3.9 Smith & Nephew
3.3.9.1 Plates and Screws
3.3.10 Stryker
3.3.10.1 Elbow
3.3.10.2 Various Fixation Devices
3.3.10.3 Various Small joint Implants and Related Tools
3.3.11 Wright Medical
3.3.11.1 Foot and Ankle
3.3.11.2 Plates and Screws
3.3.12 Zimmer Biomet
3.3.12.1 Elbow
3.3.12.2 Foot and Ankle
3.3.12.4 Plates and Screws
3.3.12.5 Shoulder
3.3.12.6 Various Fixation Devices
3.3.12.7 Various Small joint Implants and Related Tools
3.3.13 Other Companies
3.3.13.1 Elbow
3.3.13.2 Foot and Ankle
3.3.13.3 Hand and Wrist
3.3.13.4 Plates and Screws
3.4 CLINICAL TRIALS
3.4.1 Arthrex
3.4.1.1 Foot and Ankle
3.4.1.2 Plates and Screws
3.4.1.3 Shoulder
3.4.2 DePuy Synthes
3.4.2.1 Plates and Screws
3.4.2.2 Shoulder
3.4.3 Integra LifeSciences
3.4.3.1 Foot and Ankle
3.4.3.2 Staples Fixation
3.4.3.3 Hand and Wrist
3.4.3.4 Plates and Screws
3.4.3.5 Shoulder
3.4.4 Smith & Nephew
3.4.4.1 Shoulder
3.4.5 Stryker
3.4.5.1 Shoulder
3.4.6 Zimmer Biomet
3.4.6.1 Elbow
3.4.6.2 Foot and Ankle
3.4.6.3 Plates and Screws
3.4.6.4 Shoulder
3.4.7 Wright Medical
3.4.7.1 Foot and Ankle
3.4.7.2 Shoulder
3.4.8 Other Companies
3.4.8.1 Elbow
3.4.8.2 Foot and Ankle
3.4.8.3 Plates and Screws
3.4.8.4 Hand and Wrist
3.4.8.5 Plates and Screws
EUROPEAN SMALL BONE AND JOINT ORTHOPEDIC DEVICE MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 Anatomy and Pathology
4.1.1.1 Osteoarthritis
4.1.1.2 Inflammatory Arthritis
4.1.1.3 Osteoarthritis and Inflammatory Arthritis Comparison
4.1.2 Treatment
4.1.2.1 Arthroplasty
4.1.2.2 Ostectomy
4.1.3 Shoulder Joint Reconstruction Devices
4.1.4 Elbow Joint Reconstruction
4.1.5 Hand and Wrist Devices
4.1.6 Foot and Ankle Devices
4.2 CURRENCY EXCHANGE RATE
4.3 MARKET OVERVIEW
4.4 TREND ANALYSIS BY SEGMENT
4.5 DRIVERS AND LIMITERS
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 COMPETITIVE MARKET SHARE ANALYSIS
4.7 MERGERS AND ACQUISITIONS
4.8 COMPANY PROFILES
4.8.1 Acumed
4.8.2 Arthrex
4.8.3 DePuy Synthes
4.8.4 Exactech
4.8.5 Integra LifeSciences
4.8.6 Lima Corporate
4.8.7 Orthofix
4.8.8 Smith & Nephew
4.8.9 Stryker
4.8.10 Wright Medical
4.8.11 Zimmer Biomet
4.9 SWOT ANALYSIS
4.9.1 Acumed
4.9.2 Arthrex
4.9.3 DePuy Synthes
4.9.4 Exactech
4.9.5 Integra LifeSciences
4.9.6 Lima Corporate
4.9.7 Orthofix
4.9.8 Smith & Nephew
4.9.9 Stryker
4.9.10 Wright Medical
4.9.11 Zimmer Biomet
COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1 Population
5.1.2 GDP Per Capita
5.1.3 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 AUSTRIA
5.10 SWITZERLAND
5.11 PORTUGAL
PROCEDURE NUMBERS
6.1 INTRODUCTION
6.2 PROCEDURE OVERVIEW
6.3 PROCEDURES
6.3.1 Shoulder Procedures
6.3.1.1 Shoulder Replacement Procedures
6.3.1.2 Shoulder Resurfacing Procedures
6.3.1.3 Shoulder Revision Procedures
6.3.2 Elbow Procedures
6.3.2.1 Primary Elbow Implant Procedures
6.3.2.2 Radial Head Implant Procedures
6.3.3 Hand and Wrist Procedures
6.3.3.1 Wrist Replacement Procedures
6.3.3.2 Wrist Fusion Procedures
6.3.3.3 Hand Digit Implant Procedures
6.3.3.4 Distal Radius Plate and Screw Procedures
6.3.4 Foot and Ankle Procedures
6.3.4.1 Primary Ankle Replacement Procedures
6.3.4.2 Ankle Fusion Procedures
6.3.4.3 Forefoot and Midfoot Fixation Procedures
6.3.4.4 Hindfoot Procedures
6.3.4.5 Foot Digit Implant Procedures
6.3.4.6 Hammertoe Correction Procedures
SHOULDER RECONSTRUCTION MARKET
7.1 INTRODUCTION
7.1.1 Anatomy
7.1.1.1 Pathology
7.1.2 Joint Reconstruction Devices
7.1.2.1 Total Shoulder Implant
7.1.2.2 Reversed Shoulder Implants
7.1.2.3 Hemi Shoulder Implants
7.1.2.4 Resurfacing Implants
7.1.2.5 Stemless Implants
7.1.2.6 Shoulder Revision
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Shoulder Implant Market
7.3.1.1 Stemmed Total Shoulder Implant Market
7.3.1.2 Stemless Total Shoulder Implant Market
7.3.2 Reversed Shoulder Implant Market
7.3.3 Hemi Shoulder Implant Market
7.3.3.1 Stemmed Hemi Shoulder Implant Market
7.3.3.2 Stemless Hemi Shoulder Implant Market
7.3.4 Resurfacing Shoulder Implant Market
7.3.5 Revision Shoulder Implant Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
ELBOW REPAIR MARKET
8.1 INTRODUCTION
8.1.1 Pathology
8.1.2 Device Types
8.1.2.1 Primary Elbow Devices
8.1.2.2 Radial Head Elbow Devices
8.1.3 Contraindications
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Primary Elbow Implant Market
8.3.2 Radial Head Implant Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
HAND AND WRIST DEVICE MARKET
9.1 INTRODUCTION
9.1.1 Anatomy
9.1.2 Pathology
9.1.3 Treatment
9.1.4 Device Types
9.1.4.1 Definition Challenges
9.1.4.2 Total Wrist Implants
9.1.4.3 Wrist Fusion
9.1.4.4 Distal Radius Plates and Screws
9.1.4.5 Digit Implants
9.1.4.6 CMC Joint Arthroplasty of the Thumb
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Wrist Replacement Market
9.3.2 Wrist Fusion Market
9.3.3 Hand Digit Implant Market
9.3.4 Distal Radius Plate and Screw Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
FOOT AND ANKLE DEVICE MARKET
10.1 INTRODUCTION
10.1.1 Challenges in Defining the Market
10.1.2 Treatment
10.1.2.1 Total Ankle Fusion
10.1.2.2 Primary Ankle Joint Replacement
10.1.3 Foot Treatments
10.1.3.1 Hammertoe Correction Procedures
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Primary Ankle Replacement Market
10.3.2 Total Ankle Fusion Market
10.3.2.1 Ankle Fusion Cannulated Screw Market
10.3.2.2 Ankle Fusion Plate and Screw Market
10.3.2.3 Ankle Fusion Intramedullary Nail Market
10.3.3 Total Forefoot and Midfoot Fixation Market
10.3.3.1 Forefoot and Midfoot Cannulated Screw Market
10.3.3.2 Forefoot and Midfoot Plate and Screw Market
10.3.4 Hindfoot Device Market
10.3.5 Foot Digit Implant Market
10.3.6 Total Hammertoe Device Market
10.3.6.1 Hammertoe Implant Market
10.3.6.2 Hammertoe K-Wire Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
12.1 INTRODUCTION
12.2 PRESS RELEASES
12.2.1 Acumed
12.2.1.1 2017 Press Releases
12.2.1.1.1 Acumed LLC Announces Appointment of Sharon Wolfington as President and Chief Executive Officer
12.2.1.2 2016 Press Releases
12.2.1.2.1 Acumed Reaches Agreement Regarding Patent Infringement of Acutrak Screw
12.2.1.2.2 Providing Fixation for Half a Million Wrists
12.2.1.2.3 Acumed Launches New State-of-the-Art System for Ankle Fractures
12.2.2 Arthrex
12.2.2.1 2017 Press Releases
12.2.2.1.1 Arthrex® Welcomes Mark Ferguson, MD, as Director of Medical Education, Asia-Pacific (APAC) Region
12.2.2.1.2 Arthrex Partners with MSU College of Engineering and Medicine
12.2.2.2 2016 Press Releases
12.2.2.2.1 Arthrex Victorious in Patent Infringement Lawsuit Against Smith & Nephew
12.2.2.2.2 Arthrex Inc. Enters Into Partnership with NBC Sports to Provide Educational Animations
12.2.2.2.3 Synergy Extended Length Hip Arthroscope Sets
12.2.2.2.4 Knotless Distal Biceps Implant System
12.2.2.2.5 Plantar Lapidus Plate
12.2.2.2.6 Arthrex® CoolCut™ Shavers and Synergy Resection
12.2.2.2.7 DX SwiveLock® Suture Anchor, 3.5 x 12.5 mm
12.2.3 Arthrosurface
12.2.3.1 2017 Press Releases
12.2.3.1.1 Science reconfirms benefits of shoulder inlay glenoid arthroplasty for active patients
12.2.3.2 2016 Press Releases
12.2.3.2.1 Comparative Data Shows Nanofracture Superiority
12.2.3.2.2 Arthrosurface Launches OsteoMATE for the Treatment of Osteoarthritis in the Hand
12.2.3.2.3 New Motion Preserving Wrist Implant hits 1 year Milestone
12.2.3.2.4 Shoulder HemiCAP Inlay Arthroplasty Showed Lowest Comparative Revision Rate at the 5 Years Mark
12.2.3.2.5 Microfracture: Expert Opinions in Joint Preservation
12.2.4 DePuy Synthes
12.2.4.1 2017 Press Releases
12.2.4.1.1 DePuy Synthes Acquires Tissue Regeneration System’s 3D Printing Technologies to Treat Bone Defects
12.2.4.1.2 Mitek Sports Medicine Introduces Comprehensive Knee Arthroscopy Platform for ACL and Meniscal Repair
12.2.4.1.3 New report demonstrates the clinical and economic value of the Attune® knee system
12.2.4.1.4 Ethicon and Depuy Synthes introduce customized wound closure kits
12.2.4.1.5 DePuy Synthes launches ViviGen Formable™ cellular bone matrix
12.2.4.2 2016 Press Releases
12.2.4.2.1 Latest Australian Joint Registry Data Confirm Positive Early Results For the ATTUNE® Knee System
12.2.4.2.2 DePuy Synthes Companies Introduces Zero-Profile Plate with Allograft Spacer for Neck
12.2.4.2.3 Synfix® Evolution Secured Spacer System Provides Superior Biomechanical Stability1 with Enhanced Instrumentation Designed for Surgical Efficiency
12.2.4.2.4 DePuy Synthes companies introduces Zero-Profile plate with allograft spacer for neck
12.2.4.2.5 DePuy Synthes Companies launches Portable Spine Imaging System to help expand access to advanced visualization and improve patient outcomes
12.2.4.2.6 Johnson & Johnson Medical Devices Companies Value-Based Solutions Help Health Systems Address Proposed Mandatory CMS Plan for Episode Payment Models
12.2.4.2.7 New Hand System from DePuy Synthes Companies designed to address patient and surgeon needs through innovation and versatility
12.2.4.2.8 DePuy Synthes announces agreement with Materialise for 3D-Printed titanium cranio-facial implants
12.2.4.2.9 Depuy Synthes companies announces acquisition of Biomedical Enterprises, Inc., a leader in small bone fixation
12.2.4.2.10 Depuy Synthes companies announces new strategic alliance with experts in bundled payments
12.2.5 DJO Global
12.2.5.1 2017 Press Releases
12.2.5.1.1 DJO Global Announces Financial Results for First Quarter 2017
12.2.5.1.2 DJO Global Announces FDA 510(K) Clearance for Exprt® Revision Hip
12.2.5.1.3 DonJoy Revolutionizes Osteoarthritis Bracing with Introduction of TriFit Knee Brace
12.2.5.1.4 The launch of the AltiVate Anatomic shoulder system
12.2.5.1.5 DJO Global announces financial results for fourth quarter and fiscal year end 2016
12.2.5.1.6 DJO Global announces appointment of Bryan McMillan as President, Regeneration
12.2.5.1.7 Motionmd by Djo Global reaches milestone with more than 6,000 doctors now using the point-of-care automated software solution
12.2.5.2 2016 Press Releases
12.2.5.2.1 DJO Global Announces appointment of Brady Shirley as President and Chief Executive Officer
12.2.5.2.2 DJO Global announces financial results for third quarter 2016
12.2.5.2.3 Djo Global announces appointment of Mike Eklund as Chief Operating Officer and Chief Financial Officer
12.2.5.2.4 DJO Global announces financial results for second quarter 2016
12.2.5.2.5 DJO Global launches new advanced cooling Clima-Flex OA Knee Brace
12.2.5.2.6 Donjoy performance introduces pod ankle brace
12.2.5.2.7 DJO Global launches MotionMD software to optimize - clinic productivity and enhance patient experience
12.2.5.2.8 DJO Global announces planned transition of CFO, Susan Crawford
12.2.5.2.9 DJO Global announces financial results for fourth quarter and fiscal year end 2015
12.2.6 Exactech
12.2.6.1 2017 Press Releases
12.2.6.1.1 Exactech Q1 revenue up 6% to $69.5million on 21% extremities growth
12.2.6.1.2 Exactech new scientific and clinical research presented at 2017 orthopaedic research society annual meeting
12.2.6.1.3 Exactech Announces full launch of three revision systems and expansion of advanced surgical technologies at AAOS 2017 Annual Meeting, Exhibit #1433
12.2.6.1.4 Exactech 2016 revenue up 7% to $257.6 million, q4’16 revenue increased 6% to $66.2 million
12.2.6.1.5 Exactech announces divestiture of spine assets and restructuring charges
12.2.6.2 2016 Press Releases
12.2.6.2.1 Exactech Q3 revenue up 7% to $59.9 million. net income up 10% to $3.2 million. diluted eps $0.22 vs. $0.20
12.2.6.2.2 Exactech breaks ground in foot and ankle market with successful first surgery
12.2.6.2.3 New studies support Exactech’s knee, shoulder and computer-assisted surgery technologies
12.2.6.2.4 Exactech expands its computer-assisted surgery system with revision total knee replacement application
12.2.6.2.5 Exactech announces successful first surgeries with new Exactechgps® total shoulder application
12.2.6.2.6 Exactech Q2 revenue up 8% to $66.1 million. net income up 20% to $4.4 million. diluted eps $0.31 vs. $0.26.
12.2.6.2.7 Exactech announces full launch of Acapella® one cervical spacer system
12.2.6.2.8 Exactech expands competency in 3-d printing with purchase of Arcam Q10plus systems
12.2.6.2.9 Exactech Q1 revenue up 6% to $65.3 million. Net income of $4.4 million. diluted eps $0.31 vs. $0.29
12.2.6.2.10 Exactech receives FDA 510(k) clearance for Vantage™ total ankle
12.2.6.2.11 Exactech announces completion of corporate integrity agreement requirements
12.2.6.2.12 Exactech innovations simplify the complexity of revision total joint replacement
12.2.6.2.13 Exactech 2015 revenue $241.8 million, Net income $14.8 million, EPS $1.04
12.2.6.2.14 Exactech acquires Australian distributor
12.2.7 Integra LifeScience
12.2.7.1 2017 Press Releases
12.2.7.1.1 Integra LifeSciences reports first quarter 2017 financial results
12.2.7.1.2 Integra LifeSciences announces commercial expansion of the Cadence® total ankle system
12.2.7.1.3 Integra LifeSciences launches press-fit reverse shoulder for fracture for the Titan™ modular shoulder system
12.2.7.1.4 Integra LifeSciences reports fourth quarter and full-year 2016 financial results and updates 2017 full-year guidance
12.2.7.1.5 Integra LifeSciences announces acceptance of shares tendered into offer for Derma Sciences, Inc.
12.2.7.1.6 Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.
12.2.7.1.7 Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook
12.2.7.2 2016 Press Releases
12.2.7.2.1 Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
12.2.7.2.2 Integra LifeSciences Announces Key Executive Appointments
12.2.7.2.3 Integra LifeSciences Reports Third Quarter 2016 Financial Results
12.2.7.2.4 Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
12.2.7.2.5 Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe
12.2.7.2.6 Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
12.2.7.2.7 Integra LifeSciences Reports Second Quarter 2016 Financial Results
12.2.7.2.8 Integra LifeSciences Awarded $10.3 Million Department of Defense Contract
12.2.7.2.9 Integra LifeSciences to Present at the Canaccord 11th Annual Musculoskeletal Conference, Raymond James & Associates' 37th Annual Institutional Investors Conference and the Barclays Global Healthcare Conference in March 2016
12.2.7.2.10 Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health
12.2.7.2.11 Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
12.2.8 Lima Corporate
12.2.8.1 2017 Press Releases
12.2.8.1.1 Lima Corporate celebrates 10 years of 3D Printing: Trabecular Titanium
12.2.8.1.2 Michel Orsinger Joins Lima Corporate’s Advisory Board
12.2.8.2 2016 Press Releases
12.2.8.2.1 Lima Corporate enters into an innovation alliance agreement with hospital for special surgery
12.2.8.2.2 Lima corporate completes acquisition of Zimmer Biomet assets in Japan
12.2.9 Orthofix
12.2.9.1 2017 Press Releases
12.2.9.1.1 Orthofix International reports first quarter 2017 financial results
12.2.9.1.2 Orthofix introduces new brand identity for extremity fixation pediatric products
12.2.9.1.3 Orthofix International reports fourth quarter and fiscal 2016 financial results
12.2.9.1.4 Orthofix receives FDA and CE mark approvals for new bone growth stimulators
12.2.9.2 2016 Press Releases
12.2.9.2.1 Orthofix announces appointment of Alex Lukianov to Board of Directors
12.2.9.2.2 Orthofix International reports third quarter 2016 financial result
12.2.9.2.3 Orthofix announces Nass coverage policy recommendations for electrical bone growth stimulators
12.2.9.2.4 Orthofix announces first patient enrollment in osteoarthritis of the knee study
12.2.9.2.5 Orthofix International reports second quarter 2016 financial results
12.2.9.2.6 Orthofix announces publication of data demonstrating benefits of Trinity Evolution cellular bone allograft in patients undergoing anterior cervical discectomy
12.2.9.2.7 Orthofix announces 510(k) Clearance and US limited market launch of Forza PTC interbody spacer system
12.2.9.2.8 Orthofix International reports first quarter 2016 financial results
12.2.9.2.9 Orthofix announces appointment of Michael Paolucci to board of directors
12.2.9.2.10 Orthofix International reports fourth quarter and fiscal 2015 financial results
12.2.10 Smith & Nephew
12.2.10.1 2017 Press Releases
12.2.10.1.1 Smith & Nephew 2017 first quarter trading report
12.2.10.1.2 Collagenase SANTYL® Ointment advances pressure ulcers through the healing process faster, new study suggests
12.2.10.1.3 Smith & Nephew signs exclusive worldwide distribution agreement for the revolutionary MolecuLight i:XTM imaging device
12.2.10.1.4 Smith & Nephew previews NAVIO™ Robotics-assisted Total Knee Application at AAOS ahead of full market release in Q2 2017
12.2.10.1.5 Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure injury technology
12.2.10.1.6 Directorate Change
12.2.10.1.7 Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results
12.2.10.2 2016 Press Releases
12.2.10.2.1 Graham Baker appointed Chief Financial Officer
12.2.10.2.2 New WHO guidelines recommend the use of NPWT to help reduce the risk of Surgical Site Infection
12.2.10.2.3 Enabling Improved Patient Outcomes with Smith & Nephew's Pioneering Episode of Care Assurance Program (eCAP)
12.2.10.2.4 Smith & Nephew Third Quarter 2016 Trading Report
12.2.10.2.5 Smith & Nephew Invests $55 Million in New Advanced Medical Technology Manufacturing Plant
12.2.10.2.6 Post-operative use of PICO™ Single use Negative Pressure Wound Therapy improves predictability in wound healing and reduces complications following orthopaedic surgery.
12.2.10.2.7 Evidence and expert opinion highlights clinical and aesthetic benefits of PICO◊ Single-use Negative Pressure Wound Therapy in mammoplasty and oncological breast reconstructive surgery
12.2.10.2.8 Smith & Nephew’s NAVIO™ Surgical System achieves robotics-assisted milestone for total knee replacement surgery
12.2.10.2.9 Second Quarter Trading and First Half 2016 Results
12.2.10.2.10 Smith & Nephew extends its Wound Care Academy to the Kingdom of Saudi Arabia
12.2.10.2.11 CFO to leave Smith & Nephew in early 2017
12.2.10.2.12 Smith & Nephew 2016 First Quarter Trading Report
12.2.10.2.13 Smith & Nephew Continues Support of Wound Care Nurses
12.2.10.2.14 Smith & Nephew moves onto Croxley Green Business Park
12.2.10.2.15 Smith & Nephew Fourth Quarter Trading and Full Year 2015 Results
12.2.11 Stryker
12.2.11.1 2017 Press Releases
12.2.11.1.1 Stryker Orthopaedics 2016 Settlement Program reaches milestone
12.2.11.1.2 Stryker reports first quarter 2017 results
12.2.11.1.3 Stryker enabling surgeons to have a more predictable surgical experience with launch of Mako robotic-arm assisted total knee application
12.2.11.1.4 Stryker reports 2016 results and 2017 outlook
12.2.11.2 2016 Press Releases
12.2.11.2.1 Stryker reports third quarter 2016 results
12.2.11.2.2 Stryker reports second quarter 2016 results
12.2.11.2.3 Stryker acquires Stanmore Implants Worldwide Limited
12.2.11.2.4 Stryker reports first quarter 2016 results
12.2.11.2.5 Stryker completes acquisition of Physio-Control International, Inc.
12.2.11.2.6 Stryker completes acquisition of Sage Products, LLC
12.2.11.2.7 Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
12.2.11.2.8 Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
12.2.11.2.9 Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
12.2.11.2.10 Stryker Reports 2015 Results and 2016 Outlook
12.2.11.2.11 Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
12.2.11.2.12 Stryker Reports Third Quarter 2015 Results
12.2.11.2.13 Stryker Completes Acquisition of Muka Metal, A.S.
12.2.11.2.14 Stryker Receives FDA Clearance For Mako Total Knee Application
12.2.11.2.15 Stryker Reports Second Quarter 2015 Results
12.2.11.2.16 Stryker Announces Definitive Agreement to Acquire Muka Metal, A.S.
12.2.11.2.17 Stryker Reports First Quarter 2015 Results
12.2.11.2.18 Stryker Announces New $2 Billion Share Repurchase Authorization
12.2.11.2.19 Stryker Reports 2014 Results and 2015 Outlook
12.2.11.2.20 Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
12.2.12 Wright Medical
12.2.12.1 2017 Press Releases
12.2.12.1.1 Wright Medical Group N.V. reports 2017 first quarter financial results
12.2.12.1.2 Wright Medical Group N.V. reports 2016 fourth quarter and full-year financial results and provides 2017 guidance
12.2.12.2 2016 Press Releases
12.2.12.2.1 Wright Medical Group N.V. Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance
12.2.12.2.2 Wright Medical Group N.V. Announces Entry Into Metal-On-Metal Hip Litigation Settlement Agreement
12.2.12.2.3 Wright Medical Group N.V. Completes Divestiture of Large Joints Business
12.2.12.2.4 Wright Medical Group N.V. Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance
12.2.12.2.5 Wright Medical Group N.V. Highlights Recent Innovations at the American Orthopaedic Foot and Ankle Society (AOFAS) 2016 Annual Meeting
12.2.12.2.6 Wright Medical Group N.V. Announces Binding Offer Under Which Corin Orthopaedics Holdings Limited Would Acquire Wright’s Large Joints Business
12.2.12.2.7 Wright Medical Group N.V. Reports 2016 First Quarter Financial Results and Increases 2016 Guidance
12.2.12.2.8 Wright Medical Group N.V. Highlights Recent Innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2016 Annual Meeting
12.2.12.2.9 Wright Medical Group N.V. Reports 2015 Fourth Quarter and Full-Year Financial Results and Provides 2016 Guidance
12.2.13 Zimmer Biomet
12.2.13.1 2017 Press Releases
12.2.13.1.1 Zimmer Biomet reports first quarter 2017 financial results
12.2.13.1.2 Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017
12.2.13.1.3 Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure
12.2.13.1.4 Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
12.2.13.1.5 Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
12.2.13.1.6 Zimmer Biomet Announces Americas Leadership Transition
12.2.13.1.7 Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
12.2.13.1.8 Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
12.2.13.2 2016 Press Releases
12.2.13.2.1 National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal™ Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures
12.2.13.2.2 Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection (December 14, 2016)
12.2.13.2.3 Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
12.2.13.2.4 Zimmer Biomet Named Indo UK Institutes of Health Medicities Program's Preferred Orthopaedic Partner to Improve Delivery of Care in India
12.2.13.2.5 Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System - the First Commercially Available Patient-matched Glenoid Implant
12.2.13.2.6 Zimmer Biomet Reports Positive Update on Biologics Pipeline Following a Preliminary Analysis of Data from the First Pivotal Trial of Stem Cell Therapy for Critical Limb Ischemia to Reach Completion
12.2.13.2.7 Zimmer Biomet Reports Third Quarter 2016 Financial Results
12.2.13.2.8 Zimmer Biomet Acquires RespondWell® Telerehabilitation Platform for Zimmer Biomet Signature Solutions
12.2.13.2.9 Zimmer Biomet Announces Positive Comparative Data from 7-Year Follow-Up Study of Mobi-C® Cervical Disc Prosthesis for Cervical Disc Replacement
12.2.13.2.10 Zimmer Biomet Expands Foot and Ankle Portfolio Through Exclusive Global Distribution Agreement with Nextremity Solutions, Inc.
12.2.13.2.11 Zimmer Biomet Launches VANGUARD® Individualized Design Knee Replacement
12.2.13.2.12 Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
12.2.13.2.13 Zimmer Biomet Strengthens Musculoskeletal Diagnostic Offering with Acquisition of CD Diagnostics
12.2.13.2.14 Zimmer Biomet Unveils Signature Solutions™
12.2.13.2.15 Zimmer Biomet Announces Multi-Year Collaboration with Indo UK Institutes of Health to Deliver Affordable and Accessible Healthcare in India
12.2.13.2.16 Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
12.2.13.2.17 Zimmer Biomet Completes Acquisition of Cayenne Medical
12.2.13.2.18 Zimmer Biomet Secures Exclusive Global Distribution Agreement with CelgenTek Innovations Corporation
12.2.13.2.19 Zimmer Biomet Announces the Release of New Implant Technologies in Support of the Persona Knee System and Vanguard 360 Revision Knee System
List of Charts
Chart 1 1: Small Bone and Joint Orthopedic D

$11,995
$13,495
$14,995

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings